Bay National Corporation (BAYN)

0.01
OTC Markets
Prev Close 0.01
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.01 / 0.10
Exchange OTC Markets
Shares Outstanding 2.15B
Market Cap 30.00K
Div & Yield N.A. (N.A)

Latest News

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

Bayer's takeover of Monsanto is expected to receive extra scrutiny out of fears the deal could prove detrimental for European farmers.

Gene Editing Company Joins NASDAQ, Jumps Over 20% on First Day

Gene Editing Company Joins NASDAQ, Jumps Over 20% on First Day

With Calyxt, perhaps you truly can have your cake and eat it too.

Antitrust Nominee Delrahim Must Convince He Can Temper Trump Rants on Megadeals

Antitrust Nominee Delrahim Must Convince He Can Temper Trump Rants on Megadeals

Delrahim can expect questions from committee members about questionable remarks President Trump made on the campaign trail.

Ignore the Tweets! Merger Enforcement in Trump Era

Ignore the Tweets! Merger Enforcement in Trump Era

Antitrust experts say DOJ and FTC will need to tune out the president's Twitter feed.

Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan

Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan

Investors are deciding what to make of an impending overhaul of the American health care system in the wake of legislative progress out of Washington.

Billionaire David Einhorn Just Bought These 4 Stocks

Billionaire David Einhorn Just Bought These 4 Stocks

Einhorn picked up new positions in Syngenta and others.

Watchdogs Warn Trump on Bayer's Bid for Monsanto

Watchdogs Warn Trump on Bayer's Bid for Monsanto

Shares of the target rose after president-elect's team touted companies' offer to spend billions in R&D

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

Stock futures are tumbling Wednesday but are well off their lows as Republican Donald Trump is elected the next president of the United States in a surprising victory.

European Drug Companies Get an Injection From Trump Victory

European Drug Companies Get an Injection From Trump Victory

The threat of a government clampdown on drug prices is off the table with Clinton's defeat, while wider support for defensive stocks helped push pharmaceuticals higher.

Jim Cramer: I Think the EU Will Block Monsanto-Bayer Deal

Jim Cramer: I Think the EU Will Block Monsanto-Bayer Deal

Jim Cramer says he doesn't think the Monsanto and Bayer merger will be approved by regulators.

Sanofi's Likely Sweetener for Medivation Panned

Sanofi's Likely Sweetener for Medivation Panned

The French drugmaker is reportedly thinking about including a CVR in its $9.3 billion bid for Medivation, but the move is unlikely to be enough to entice the target's shareholders.

Global Pharma Players Likely to Flock to Medivation

Global Pharma Players Likely to Flock to Medivation

AstraZeneca, Bayer, Eli Lilly and Merck are just a few of the names that may join a bidding war for the cancer drug maker, analysts say.

ChemChina Beats Monsanto to Win Syngenta in $44B Takeover

ChemChina Beats Monsanto to Win Syngenta in $44B Takeover

China National Chemical Corp. is making history with its nearly $44 billion deal to acquire Swiss agrichemical producer Syngenta.

Why DuPont Will Make a Major Comeback

Why DuPont Will Make a Major Comeback

The currently unloved chemical giant is poised to rebound on the strength of new leadership and internal streamlining.

European Exporters Offer 'Compelling' Stock Plays, but Watch Out for Greece

European Exporters Offer 'Compelling' Stock Plays, but Watch Out for Greece

Stocks may be cheaper in Europe than the U.S., but the political risk surrounding Greece doesn't bode well for the region, one strategist said.

Stocks Give Up Early Gains; 3M, Apple Disappoint

Stocks pull back after early gains as investors sort through big batch of earnings

Stock Futures Rise On Strong Global Earnings

Stock futures climb following strong earnings globally; investors eye weekly jobless claims

Stocks Up On AstraZeneca, Bayer, Telecom Earns

Stocks Up On AstraZeneca, Bayer, Telecom Earns

Upbeat earnings, economic news gives world markets a lift; euro hits 11-week high

Bayer Q4 Net Income Up 44 Percent

Bayer Q4 Net Income Up 44 Percent

German chemical, pharmaceutical company Bayer says Q4 net income rose 44 percent

Pressure Rises To Stop Antibiotics In Agriculture

Pressure Rises To Stop Antibiotics In Agriculture

Pressure rises to stop antibiotics in agriculture; animals fed 70 percent of US antibiotics

Swiss Fine Drug Firms $5.7M For Price-fixing

Swiss fine Pfizer, Eli Lilly, Bayer $5.7M for price-fixing of erectile dysfunction drugs

Ecuador To Make Cheap Versions Of Patented Drugs

Pharmaceutical cos. accept Ecuador's decision to produce low-cost versions of patented drugs

Bayer Q3 Net Income Falls 10 Pct

German drug, chemical company Bayer's Q3 net income falls 10 percent to euro249 million

German Investor Confidence Slips In October

German Investor Confidence Slips In October

Survey shows dip in German investor confidence amid mixed economic signals

Mistras Group IPO Set For Thursday

Mistras Group IPO Set For Thursday

Mistras Group to offer 8.7 million shares, raising up to $139 million, at IPO Thursday